Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
Philpott CM, Erskine S, Hopkins C, Kumar N, Anari S, Kara N, Sunkaraneni S, Ray J, Clark A, Wilson A; CRES group; Erskine S, Philpott C, Clark A, Hopkins C, Robertson A, Ahmed S, Kara N, Carrie S, Sunkaraneni V, Ray J, Anari S, Jervis P, Panesaar J, Farboud A, Kumar N, Cathcart R, Almeyda R, Khalil H, Prinsley P, Mansell N, Salam M, Hobson J, Woods J, Coombes E. Philpott CM, et al. Among authors: hopkins c. Respir Res. 2018 Jun 27;19(1):129. doi: 10.1186/s12931-018-0823-y. Respir Res. 2018. PMID: 29945606 Free PMC article.
Rhinosinusitis symptoms, smoking and COPD: Prevalence and associations.
Caminha GP, Pizzichini E, Lubianca Neto JF, Hopkins C, Moreira JDS, Pizzichini MMM. Caminha GP, et al. Among authors: hopkins c. Clin Otolaryngol. 2018 Dec;43(6):1560-1565. doi: 10.1111/coa.13215. Epub 2018 Sep 19. Clin Otolaryngol. 2018. PMID: 30152142
Unified Airway Disease: Medical Management.
Shamil E, Hopkins C. Shamil E, et al. Among authors: hopkins c. Otolaryngol Clin North Am. 2023 Feb;56(1):157-168. doi: 10.1016/j.otc.2022.09.012. Epub 2022 Oct 18. Otolaryngol Clin North Am. 2023. PMID: 36266108 Review.
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, Chaker A, Diamant Z, Gevaert P, Han J, Hopkins C, Hox V, Klimek L, Lund VJ, Lee S, Luong A, Mullol J, Peters A, Pfaar O, Reitsma S, Toppila-Salmi S, Scadding GK, Sedaghat AR, Viskens AS, Wagenmann M, Hellings PW. Fokkens WJ, et al. Among authors: hopkins c. Rhinology. 2024 Jan 13. doi: 10.4193/Rhin23.415. Online ahead of print. Rhinology. 2024. PMID: 38217529
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial.
Emson C, Han JK, Hopkins C, Asimus S, Cann JA, Chain D, Wu Y, Reddy Y, McCrae C, Cohen D, Kreindler JL, Werkström V, Jison M, Wagenmann M, Bachert C. Emson C, et al. Among authors: hopkins c. Br J Clin Pharmacol. 2024 May 7. doi: 10.1111/bcp.16087. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38715387
1,182 results